TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Oncotarget | February 7, 2017 | Volume: 8 | Issue: 11 | Pages: 18381-18398
10.18632/oncotarget.15110
| PMID 28179588